|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Amortization of patent formulations | |||||
| Amortization of other intangibles | |||||
| Inventory write-off and disposal | |||||
| Depreciation of property and equipment | |||||
| Amortization of debt issuance costs | |||||
| Deferred taxes | |||||
| Tax Receivable Agreement liability adjustment | |||||
| Share-based compensation expense | |||||
| Loss on extinguishment of debt | |||||
| Acquisition-related costs in investing activities | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Other assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Acquisition-related costs | |||||
| Purchase of intangible assets | |||||
| Purchase and development of software | |||||
| Purchase of investment in nonconsolidated entity | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from the issuance of stock | |||||
| Proceeds from exercise of stock options | |||||
| Principal payments of 2022 Term Loan Facility | |||||
| Payment related to shares withheld to cover tax withholding obligations for options and for SARs | |||||
| Stock options | |||||
| SARs | |||||
| Payments made pursuant to Tax Receivable Agreement | |||||
| Proceeds from the issuance of 2022 Term Loan Facility | |||||
| Payments of debt issuance costs | |||||
| Net cash used in financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents - beginning of year | |||||
| Cash and cash equivalents - end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash (refunded) paid for income taxes, net | |||||
| Cash paid during the year for interest | |||||
| Supplemental disclosure of noncash activities: | |||||
| Offering and strategic transition costs included in accounts payable and accrued expenses | |||||
| Increase in Related Party payable pursuant to Tax Receivable Agreement | |||||
| Noncash exercise of stock options | |||||
| Cash settled units liability reclassification to additional paid in capital | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
| Purchases of software not yet paid | |||||
Loading...